Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Zur Ergebnisliste
Ergebnis 3 von 480395
    Datensatz exportieren als...
  • BibTeX
Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes
The New England journal of medicine, 2022-09, Vol.387 (13), p.1161-1172
2022

Details

Autor(en) / Beteiligte
Titel
Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes
Ist Teil von
  • The New England journal of medicine, 2022-09, Vol.387 (13), p.1161-1172
Ort / Verlag
United States: Massachusetts Medical Society
Erscheinungsjahr
2022
Link zum Volltext
Quelle
Alma/SFX Local Collection
Beschreibungen/Notizen
  • In a 13-week, randomized trial involving persons 6 to 79 years of age with type 1 diabetes, use of a bionic pancreas was associated with a greater reduction in the glycated hemoglobin level than standard care.
Sprache
Englisch
Identifikatoren
ISSN: 0028-4793
eISSN: 1533-4406
DOI: 10.1056/NEJMoa2205225
Titel-ID: cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10028490
Format
–
Schlagworte
Adolescent, Adolescent Medicine, Adult, Age, Aged, Algorithms, Automation, Bionics, Bionics - instrumentation, Blood Glucose - analysis, Blood Glucose Self-Monitoring - instrumentation, Blood Glucose Self-Monitoring - methods, Body weight, Carbohydrates, Care and treatment, Child, Childhood Diseases, Clinical Medicine, Clinical Medicine General, Closed loop systems, Diabetes, Diabetes mellitus (insulin dependent), Diabetes Mellitus, Type 1 - blood, Diabetes Mellitus, Type 1 - drug therapy, Diabetic ketoacidosis, Diet, Endocrinology, FDA approval, Gastroenterology, Glucose, Glucose monitoring, Glycated Hemoglobin - analysis, Hemoglobin, Humans, Hypoglycemia, Hypoglycemic Agents - administration & dosage, Hypoglycemic Agents - adverse effects, Hypoglycemic Agents - therapeutic use, Insulin, Insulin - administration & dosage, Insulin - adverse effects, Insulin - therapeutic use, Insulin Aspart - administration & dosage, Insulin Aspart - adverse effects, Insulin Aspart - therapeutic use, Insulin Infusion Systems - adverse effects, Insulin Lispro - administration & dosage, Insulin Lispro - adverse effects, Insulin Lispro - therapeutic use, Ketoacidosis, Kidney diseases, Middle Aged, Nutrition, Nutrition (Pediatrics), Pancreas, Pediatrics, Pediatrics General, Teenagers, Testing, Type 1 diabetes, Young Adult

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX